Both mandibular advancement device and continuous positive airway pressure therapy significantly reduced daytime continuous diastolic blood pressure to a similar extent in patients with obstructive sleep apnea.
RCT (n=40)
Open-label
Crossover
No
Does mandibular advancement therapy compared to CPAP improve daytime cardiac autonomic function in patients with obstructive sleep apnea?
Both mandibular advancement therapy and CPAP provide similar beneficial reductions in daytime diastolic blood pressure in patients with obstructive sleep apnea, although CPAP is more effective at eliminating respiratory events.
Tasa de eventos absoluta: 60.5% vs 60.9%
PURPOSE: The present study compared the effects of mandibular advancement therapy (MAD) with continuous positive airway pressure therapy (CPAP) on daytime cardiac autonomic modulation in a wide range of obstructive sleep apnea (OSA) patients under controlled conditions in a randomized, two-period crossover trial. METHODS: Forty OSA patients underwent treatment with MAD and with CPAP for 12 weeks each. At baseline and after each treatment period, patients were assessed by polysomnography as well as by a daytime cardiac autonomic function test that measured heart rate variability (HRV), continuous blood pressure (BP), and baroreceptor sensitivity (BRS) under conditions of spontaneous breathing, with breathing at 6, 12, and 15/min. RESULTS: Both CPAP and MAD therapy substantially eliminated apneas and hypopneas. CPAP had a greater effect. During daytime with all four conditions of controlled breathing, three-minute mean values of continuous diastolic BP were significantly reduced for both MAD and CPAP therapy. At the same time, selective increases due to therapy with MAD were found for HRV high frequency (HF) values. No changes were observed for BRS in either therapy mode. CONCLUSIONS: These findings indicate that both MAD and CPAP result in similar beneficial changes in cardiac autonomic function during daytime, especially in blood pressure. CPAP is more effective than MAD in eliminating respiratory events.
Glos et al. (Tue,) conducted a rct in Obstructive sleep apnea (OSA) (n=40). Mandibular advancement device (MAD) vs. Continuous positive airway pressure (CPAP) was evaluated on Continuous diastolic blood pressure during spontaneous breathing (mmHg). Both mandibular advancement device and continuous positive airway pressure therapy significantly reduced daytime continuous diastolic blood pressure to a similar extent in patients with obstructive sleep apnea.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: